Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

17.15
Delayed Data
As of 4:02pm ET
 +0.04 / +0.23%
Today’s Change
15.22
Today|||52-Week Range
51.51
-52.69%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
AssetsCash1.6B987.1M897.8M598.5M
 
 
 
 
 
Short Term Investment Cash-5.5B-546.8M-90.8M-311.6M
 
 
 
 
 
Cash & Short Term Investments1.6B1.7B909.7M615.4M
 
 
 
 
 
 
ReceivablesReceivables8.1B7.5B7.2B7.3B
 
 
 
 
 
 
InventoriesInventories5.4B4.9B5.0B5.1B
 
 
 
 
 
 
Current AssetsPrepaid Expenses--1.4B957.6M870.2M
 
 
 
 
Other Current Assets2.4B1.4B698.3M655.4M
 
 
 
 
 
Current Assets17.4B16.9B14.8B14.6B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross12.2B11.9B12.1B12.2B
 
 
 
 
 
Depreciation-3.9B-3.8B-4.0B-4.2B
 
 
 
 
 
Intangible Assets69.9B65.8B66.0B61.6B
 
 
 
 
 
Other Assets71.9B66.7B67.3B62.8B
 
 
 
 
 
Total Assets98.8B92.8B91.0B86.3B
 
 
 
 
 
 
LiabilitiesAccounts Payable5.0B2.2B2.4B2.3B
 
 
 
 
 
Short Term Debt3.7B3.3B1.9B1.2B
 
 
 
 
 
Accrued Expenses1.3B3.4B2.5B2.8B
 
 
 
 
 
Other Current Liabilities10.7B12.2B10.9B11.2B
 
 
 
 
 
Other Liabilities19.3B18.5B15.9B15.4B
 
 
 
 
 
 
Total LiabilitiesLong Term Debt33.2B32.5B32.6B33.8B
 
 
 
 
 
Deferred Taxes-6.8B-4.5B-4.5B-4.7B
 
 
 
 
 
Other Liabilities1.4B1.6B1.6B2.0B
 
 
 
 
 
Total Liabilities61.7B57.8B55.4B56.7B
 
 
 
 
 
 
EquityMinority Interest-2.0M-999.2K-4.1M--
 
 
 
 
Preferred Stock3.6B3.6B3.6B3.6B
 
 
 
 
 
Common Equity31.5B29.7B30.3B24.4B
 
 
 
 
 
Total Shareholder Equity35.1B33.3B33.9B28.0B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding1.0B1.0B1.0B1.0B
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.